Useful Advices - Business

The bursting of the dotcom bubble in the year 2001 was a defining moment in the global web industry. People believed that the web had been given far more sign

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ificance than it merited, not withstanding that initial glitches are a common feature of all technological revolutions. The shakeouts in fact mark the beginni

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ng of new and innovative technology ready to replace the old and the redundant.

The concept of "Web 2.0" thus began with a conference brainstorming session b

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

etween O'Reilly and MediaLive International. Dale Dougherty, web pioneer and O'Reilly VP, believed that the web has not lost any importance; in fact with new

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

nd exciting applications coming up daily, it was assuming far more significance than it had in the past. The companies that had survived the collapse seemed t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

o have several things in common and the collapse was actually a turning point for the web. In consonance with this theory, they agreed to coin a phrase known

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

as Web 2.0 referring to proposed second generation web based services. They used this term as a title for a series of conferences resulting in the birth of th

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e Web 2.0 Conference. It is hinted to be an upgrade over the World Wide Web and emphasizes online collaboration and sharing among users.

Although, its exact

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

eaning is open to debate, the last and most accepted definition of Web 2.0, according to Tim O'Reilly is: "Web 2.0 is the business revolution in the computer

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

industry caused by the move to the Internet as platform, and an attempt to understand the rules for success on that new platform. Chief among those rules

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

is this: Build applications that harness network effects to get better the more people use them.

In their first Web 2.0 Conference, Tim O'Reilly and Joh

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

n Battelle summarized key principles of Web 2.0 applications as follows

The web as a platform for web based services allowing users to use applicat

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ons through a browser

Data as the driving force – users owning and controlling data

Network effects created through an architecture of pa

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

rticipation and democracy

Innovation in assembly of systems and sites is "open source" development

Lightweight business models enabled by

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

content and service syndication

End of the software adoption cycle

Rich, interactive, user friendly interface based on Ajax and other sim

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ilar frameworks

Easy to pick up by early adopters

The complex and evolving technology infrastructure of Web 2.0 and the web based servi

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

es includes server-software, content-syndication, messaging-protocols, standards-based browsers with plug-ins and extensions, and various client-applications.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

These differing but complementary approaches provide Web 2.0 with information-storage, creation, and dissemination capabilities that go beyond what the publi

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

c formerly expected of web-sites.

There still exists huge controversy on the Web 2.0 and the web based services it can offer– where some believe it to be a m

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

arketing buzzword others swear by its wisdom. Whatever it might be, the Web 2.0 like several other critical concepts is flexible without a rigid boundary line

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/394/usefuladvices-Web-20.html">Web 2.0</a>

BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/394/usefuladvices-Web-20.html]Web 2.0[/url]

In most breeds of cattle, horns are produced by a recessive gene, and the polled gene is dominant. If you breed two animals with horns, the offspring will have horns; but if you breed two polled animals, the offspring could be horned or polled.

Our senses are finely tuned to reject anything that looks, smells, tastes, feels, or sounds different than what we prefer. In an increasingly complex and diverse global environment, organizations run the danger of overlooking great opportunities right under their noses and in front of their eyes because the opportunities do not fit the conventional ideal.

With retailers wanting a constant flow of newness, it's more important than ever for inventors and corporations to invent with consumers in mind and give them something new to go into the stores for.

Tags

Links

Useful Advices - Web 2.0

Related Articles: